A new blended genome genetic test being studied in a major clinical trial may help identify men at highest risk of aggressive prostate cancer and personalise screening strategies.

Studies on whether pelvic lymph node dissection (PLND) provides a survival benefit in men with prostate cancer having surgery ...

If you’re keeping score, it’s Jarvis Greer two and prostate cancer: zero. Zilch. Nil. Nothing! But this latest battle has taken a toll on the retired Action News 5 sports director.

A man with stage four cancer has described how he saved his twin brother's life by insisting on a blood test. Andy Gissing, ...

PSA and Ki-67 tumour markers may identify high-risk metastatic castration-sensitive prostate cancer and inform treatment choices. Find out more.

Listen to Jacksonville’s Morning News every Friday for good news in Jacksonville, presented by UF Health Proton Therapy Institute.

Despite a decided shortage of placebo-controlled trials in humans to support that advice, the business of longevity is booming, thanks in large part to sleek direct-to-consumer marketing delivered by ...

Step by step, little by little, we are learning how to act on this new staging information,’ one investigator says.

A newer type of prostate cancer scan called 64 Cu-SAR-bisPSMA found more than twice as many cancer spots as a commonly used PSMA PET scan in men whose prostate-specific antigen (PSA) was rising after ...

When PSA rises after surgery, PSMA PET/CT detects cancer missed by conventional imaging ...

In a new study published in the journal Nature Genetics, Haolong Li, PhD, a researcher at Fred Hutch Cancer Center, and colleagues developed a way to monitor androgen receptor levels inside living ...

New research appearing in the Journal of the National Comprehensive Cancer Network found that incorporating information from ...